https://doi.org/10.4081/hmr.v3i3.568

High-dose CHOP in the rituximab era: still a place?

Vol. 3 No. 3: 7th Meeting New Insights in Hematology Venice, Italy, 26-29 April 2009
Published: June 12, 2009
Abstract Views: 203
PDF: 235
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

B Coiffier
support@pagepress.org
The combination of rituximab plus CHOP (R-CHOP) has dramatically changed the outcome of patients with diffuse large B-cell lymphoma but there are still eras where the results obtained with RCHOP chemotherapy are not so satisfying. If R-CHOP is associated with 5-year progression-free survival (PFS) and overall survival (OS) of 70% and 80%, respectively, in patients with good risk presentation (IPI score <3), this is not the case in higher risk patients. For elderly patients, increasing the risk of chemotherapy dose is not a possibility because of the potential toxicity; however, this is the case for young patients with adverse prognosis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Coiffier, B. (2009). High-dose CHOP in the rituximab era: still a place?. Hematology Meeting Reports (formerly Haematologica Reports), 3(3). https://doi.org/10.4081/hmr.v3i3.568
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).